Cocrystal Pharma Stock Today
| COCP Stock | USD 1.59 0.07 4.22% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Cocrystal Pharma is selling at 1.59 as of the 19th of March 2025; that is 4.22 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.59. Cocrystal Pharma has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious andor chronic viral diseases. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp Dohme Corp. The company has 10.17 M outstanding shares of which 14.37 K shares are currently shorted by private and institutional investors with about 0.55 trading days to cover. More on Cocrystal Pharma
Moving against Cocrystal Stock
Cocrystal Stock Highlights
Cocrystal Pharma (COCP) is traded on NASDAQ Exchange in USA. It is located in 19805 North Creek Parkway, Bothell, WA, United States, 98011 and employs 12 people. Cocrystal Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.9 M. Cocrystal Pharma conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 10.17 M outstanding shares of which 14.37 K shares are currently shorted by private and institutional investors with about 0.55 trading days to cover.
Cocrystal Pharma currently holds about 51.03 M in cash with (14.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cocrystal Pharma Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Cocrystal Pharma is $16.9 Million. Cocrystal Pharma retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Cocrystal Ownership Details
Cocrystal Pharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cocrystal Pharma market risk premium is the additional return an investor will receive from holding Cocrystal Pharma long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | 0.8134 | |||
| Treynor Ratio | (0.20) |
Cocrystal Stock Against Markets
Cocrystal Pharma Corporate Executives
Elected by the shareholders, the Cocrystal Pharma's board of directors comprises two types of representatives: Cocrystal Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cocrystal. The board's role is to monitor Cocrystal Pharma's management team and ensure that shareholders' interests are well served. Cocrystal Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cocrystal Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sam Lee | Co-Founder and Pres | Profile | |
| Roger Kornberg | Independent CoFounder | Profile | |
| Prof Kornberg | Independent CoFounder | Profile |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.